Dallas Jury Awards $247 Million to Six New York Patients Over J&J's Defective Pinnacle Hip Implants
Won by The Lanier Law Firm.
A Dallas federal jury awarded six New York patients $247 million against Johnson and Johnson and its DePuy unit, finding that the metal-on-metal Pinnacle hip implant system was defectively designed and that the company concealed known risks from patients and surgeons.
What happened
DePuy Orthopaedics marketed its Pinnacle Acetabular Cup System as a long-lasting solution for patients who needed total hip replacement. The device was built around a metal-on-metal bearing: a cobalt-chromium ball rotating inside a cobalt-chromium socket. That friction, sustained over years of daily movement, shed metallic particles and ions into surrounding tissue. For a significant portion of recipients, the debris triggered metallosis, a condition involving tissue death, bone erosion, and severe inflammation that typically required revision surgery to remove and replace the device. DePuy discontinued the Pinnacle metal-on-metal line in 2013, following regulatory changes and mounting failure data.
By late 2017, more than 9,000 cases involving the Pinnacle implant had been consolidated before U.S. District Judge Ed Kinkeade in the Northern District of Texas as part of MDL 2244. Six residents of New York, ranging in age from 52 to 88 and spanning a variety of occupations and backgrounds, had each undergone implant surgery and later faced painful revisions. Their cases were selected as the fourth set of bellwether trials in the litigation, designed to test how juries would evaluate the evidence and the plaintiffs' injuries.
W. Mark Lanier led trial counsel for the six plaintiffs through a nine-week proceeding. The plaintiffs' theory centered on two points: that the metal-on-metal design was unreasonably dangerous given the known wear characteristics of cobalt-chromium components, and that DePuy's own executives were aware of the elevated failure and ion-release risks yet directed sales representatives to tell surgeons the device had been improved rather than disclose the underlying data. Internal company communications became key evidence at trial.
The jury deliberated for 14 hours before returning, on November 16, 2017, a total verdict of $247 million. The award comprised $78 million in compensatory damages across the six plaintiffs and $168 million in punitive damages against J&J and DePuy. It was Lanier's third consecutive plaintiff victory in the Pinnacle bellwether series.
Johnson and Johnson disputed the verdict and was expected to appeal. The earlier Pinnacle bellwether verdicts in this MDL ($502 million from trial one and $1.04 billion from trial two) were both subsequently reduced or challenged in post-trial and appellate proceedings, a pattern the company indicated it intended to pursue with all bellwether outcomes.
Sources
This account is drawn from contemporaneous public reporting and the court record.